Jean-Christophe Ianotto Selected Research

PMitCEBO protocol

12/2021

Prognostic value of interim FDG PET-CT in patients older than 60 years with diffuse large B-cell lymphoma treated by PMitCEBO plus rituximab. Comparison between Deauville 5-point scale and International Harmonization Project criteria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Christophe Ianotto Research Topics

Disease

18	Neoplasms (Cancer) 01/2024 - 09/2010
10	Primary Myelofibrosis (Myelosclerosis) 07/2021 - 07/2009
7	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 01/2017
6	Thrombosis (Thrombus) 01/2024 - 01/2017
6	Hemorrhage 11/2023 - 01/2017
6	Essential Thrombocythemia 11/2023 - 11/2012
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2021 - 06/2008
5	Polycythemia Vera 08/2021 - 05/2008
4	Lymphoma (Lymphomas) 01/2014 - 03/2010
2	Atrial Fibrillation 10/2022 - 01/2022
2	Anemia 01/2021 - 12/2017
2	Splenomegaly 01/2021 - 01/2016
2	Thrombocytosis (Thrombocythemia) 10/2018 - 03/2013
2	Infections 01/2018 - 08/2013
2	Neutropenia 01/2018 - 08/2013
2	Thrombocytopenia (Thrombopenia) 12/2017 - 01/2017
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 09/2016 - 09/2009
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2015 - 06/2010
1	Hyperlipidemias (Hyperlipidemia) 09/2023
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2021
1	Polycythemia (Erythrocytosis) 08/2021
1	Aspergillosis 01/2020
1	Febrile Neutropenia 01/2018
1	Fever of Unknown Origin 01/2018
1	Leukopenia 12/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2017
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 11/2017
1	Venous Thromboembolism 03/2017
1	Residual Neoplasm 01/2017
1	Leukemia 01/2017
1	Pericarditis 07/2015
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2014
1	Blast Crisis (Blast Phase) 11/2013
1	Aplastic Anemia (Anemia, Hypoplastic) 08/2013
1	Gastritis 01/2013
1	Encephalitis (Encephalitis, Rasmussen) 01/2013
1	Intraocular Lymphoma 09/2011

Drug/Important Bio-Agent (IBA)

7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2022 - 06/2016
6	Tyrosine Kinase InhibitorsIBA 01/2023 - 11/2013
5	InterferonsIBA 07/2020 - 03/2013
4	Syntex adjuvant formulationIBA 06/2023 - 11/2012
4	Imatinib Mesylate (Gleevec)FDA Link 12/2022 - 01/2017
4	AnticoagulantsIBA 01/2022 - 10/2017
3	CalreticulinIBA 07/2021 - 03/2017
3	ruxolitinibIBA 01/2021 - 01/2016
2	Hemoglobins (Hemoglobin)IBA 01/2024 - 08/2021
2	Hydroxyurea (Hydrea)FDA LinkGeneric 10/2022 - 01/2016
2	Rituximab (Mabthera)FDA Link 12/2021 - 01/2013
2	Janus Kinase InhibitorsIBA 01/2021 - 01/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 08/2013
2	CytokinesIBA 01/2017 - 11/2015
2	Lenalidomide (CC 5013)FDA Link 09/2016 - 09/2009
1	Immunoglobulins (Immunoglobulin)IBA 09/2023
1	apixabanIBA 01/2022
1	RivaroxabanIBA 01/2022
1	anagrelide (Agrylin)FDA LinkGeneric 05/2021
1	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 01/2021
1	Janus KinasesIBA 01/2021
1	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 01/2021
1	fedratinibIBA 01/2021
1	posaconazole FDA Link 01/2020
1	Lomustine (CCNU)FDA Link 11/2018
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 11/2018
1	lipoarabinomannan (LAM)IBA 11/2018
1	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2018
1	Vitamin K FDA Link 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 11/2017
1	Interferon-gamma (Interferon, gamma)IBA 01/2017
1	Dasatinib (BMS 354825)FDA Link 01/2017
1	nilotinib FDA Link 01/2017
1	Natural Killer Cell ReceptorsIBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Heparin (Liquaemin)FDA LinkGeneric 11/2015
1	Heparitin Sulfate (Heparan Sulfate)IBA 11/2015
1	GlycosaminoglycansIBA 11/2015
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 11/2015
1	Leukotriene B4IBA 11/2014
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 11/2014
1	Filgrastim (Neupogen)FDA Link 01/2014
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2014
1	Biosimilar PharmaceuticalsIBA 01/2014
1	Azacitidine (5 Azacytidine)FDA Link 11/2013
1	Immunosuppressive Agents (Immunosuppressants)IBA 08/2013
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2013
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 08/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2013
1	Monoclonal AntibodiesIBA 01/2013

Therapy/Procedure

16	Therapeutics 11/2023 - 07/2009
7	Drug Therapy (Chemotherapy) 06/2021 - 09/2011
2	Erythrocyte Transfusion 12/2017 - 01/2017
2	Stem Cell Transplantation 03/2013 - 03/2010
1	Secondary Prevention 01/2022
1	PMitCEBO protocol 12/2021
1	Plasma Exchange 08/2019
1	Homologous Transplantation 11/2018
1	Electrodes (Electrode) 06/2016
1	Catheters 08/2013
1	Radiotherapy 09/2011